CD8A and neoplasm: Indeed, by transferring cisplatin-induced SASP and boosting senescence, it was possible to sensitizes ovarian tumor to anti-PD-1 antibody and improving the survival of tumor-bearing mice in an immunocompetent, syngeneic model, probably thanks to the infiltration of activated CD8+ T cells and dendritic cells in the tumor surrounding (Hao et al., 2021).